Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] will proceed with a Phase 3 clinical trial of losmapimod is big news for the FSHD community. It means that the FDA has considered the data from the Phase 2b […]
The “Women on Wellness” Zoom group is for women with FSHD to discuss female-focused health and other topics. These notes are from the November 3, 2021, meeting, which began with […]
Dear Colleagues, The 2013 FSH Society FSHD International Research Consortium workshop will be held on Monday & Tuesday, October 21-22, 2013, at the Massachusetts Institute of Technology, in Cambridge, Massachusetts. […]
[…] questions we are often asked is how will pregnancy and child-bearing affect an individual with FSHD? And because FSHD is passed on from generation to generation, what are the options […]
[…] boys. This finding is an exciting proof-of-principle for diseases such as facioscapulohumeral muscular dystrophy ( FSHD), a genetic condition that affects around 1 in 8,000 men, women and children and […]
